SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-21-008994
Filing Date
2021-04-16
Accepted
2021-04-16 12:56:25
Documents
4
Period of Report
2021-04-16

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 789064
2 img_001.jpg GRAPHIC 25888
3 proxy_001.jpg GRAPHIC 178231
4 proxy_002.jpg GRAPHIC 98974
  Complete submission text file 0001493152-21-008994.txt   1207865
Mailing Address 711 STEWART AVENUE GARDEN CITY NEW YORK NY 11530
Business Address 711 STEWART AVENUE GARDEN CITY NEW YORK NY 11530 (215) 345-0919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-21617 | Film No.: 21830739
SIC: 2834 Pharmaceutical Preparations